Information was received from a patient who was implanted with an implantable neurostimulator (ins) for urinary dysfunction/sacral nerve stim and gastrointestinal/ pelvic floor.It was reported that in around (b)(6) 2023 or early (b)(6) 2024, their ins had started shocking them for 15 minutes at a time and they stated at the time they thought "something's gotta be wrong" and they turned it off.The patient stated that once they turned it off, they saw a message with a stethoscope on the programmer that said "see doctor" and showed a little box and after that they weren't able to connect to the device because theins had died.They stated they would reach out to their health care provider (hcp) to discuss removal options.Patient stated they had an upcoming appointment with their hcp scheduled for (b)(6) 2024 but that they would try to get in to an earlier appointment to address the issue.
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|